Direvo Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 10

Direvo General Information


Developer of biotechnology products designed to be used for industrial usage, chemical processing and medical applications. The company's products are biology-based and process sustainable resources for use in non-pharmaceutical industries with a focus on biomass conversion, enabling clients to avail sustainable and profitable processes which are urgently required by the developing bio-economy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Nattermannallee 1
  • 50829 Cologne
  • Germany
+49 0221 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Direvo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 000.00 Completed Generating Revenue
5. Later Stage VC 18-Mar-2013 00.000 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 14-Apr-2010 00.00 000.00 000.00 Completed Generating Revenue
3. Early Stage VC 01-Feb-2009 00.000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 16-Sep-2008 $11.6M $11.6M Completed Generating Revenue
1. Buyout/LBO 16-Sep-2008 Completed Generating Revenue
To view Direvo’s complete valuation and funding history, request access »

Direvo Executive Team (7)

Name Title Board Seat Contact Info
Marcus Kind Chief Executive Officer
Albrecht Läufer Ph.D Senior Advisor
Klaudija Milos Senior Advisor
You’re viewing 3 of 7 executive team members. Get the full list »

Direvo Board Members (6)

Name Representing Role Since
Gerhard Prante Self Board Member 000 0000
Karl-Gerhard Seifert Direvo Chairman 000 0000
Stefan Fischer TVM Capital Life Science Board Member 000 0000
You’re viewing 3 of 6 board members. Get the full list »

Direvo Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Direvo Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sanders Morris Harris PE/Buyout Minority 000 0000 000000 0
Wlbern Equity Partners Venture Capital Minority 000 0000 000000 0
Sparkasse KölnBonn PE/Buyout Minority 000 0000 000000 0
Bankhaus Wölbern Other Minority 000 0000 000000 0
Danisco Venture Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Direvo Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 000000 06-Nov-2007 000000000000000000 Biotechnology 000000 000 0ü000 00.0
To view Direvo’s complete acquisitions history, request access »